Personal information

Keywords

Health Economics, Outcomes Research, Mapping, Pharmacoeconomics

Countries

Czech Republic

Activities

Collapse all

Employment (2)

Value outcomes s.r.o.: Prague, CZ

2013-09 to present | Health Economy Analyst
Employment
Source: Self-asserted source
Tomas Mlcoch

Institute of Health Economics and Technology Assessment: Prague, CZ

2013-09 to present | Health Economy Analyst
Employment
Source: Self-asserted source
Tomas Mlcoch

Education and qualifications (1)

University of Economics Prague: Prague, CZ

2008-09 to 2014-02 | MSc. (Department of Economics)
Education
Source: Self-asserted source
Tomas Mlcoch

Works (5)

Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension

Expert Review of Pharmacoeconomics & Outcomes Research
2022-11-17 | Journal article
DOI: 10.1080/14737167.2022.2126833
Contributors: Eva Ornstová; Jan Tužil; Kateřina Chadimová; Tomáš Mlčoch; Tomáš Doležal
Source: check_circle
Crossref

Time in remission as an alternative outcome measure for rheumatoid arthritis: a 10-year prospective study of 2618 new users of anti-TNF

Rheumatology
2022-05-30 | Journal article
DOI: 10.1093/rheumatology/keab737
Contributors: Jan Tužil; Tomáš Mlčoch; Jakub Závada; Michal Svoboda; Karel Pavelka; Tomáš Doležal
Source: check_circle
Crossref

Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn’s Disease

Applied Health Economics and Health Policy
2021-07-11 | Journal article
DOI: 10.1007/s40258-020-00628-y
Contributors: Tomas Mlcoch; Barbora Decker; Tomas Dolezal
Source: check_circle
Crossref

Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry

Expert Opinion on Biological Therapy
2020-02-01 | Journal article
DOI: 10.1080/14712598.2020.1694900
Contributors: Jan Tužil; Tomáš Mlčoch; Jitka Jirčíková; Jakub Závada; Lucie Nekvindová; Michal Svoboda; Michal Uher; Zlatuše Křístková; Jiří Vencovský; Karel Pavelka et al.
Source: check_circle
Crossref

Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis

The Patient - Patient-Centered Outcomes Research
2018-06-21 | Journal article
DOI: 10.1007/s40271-017-0285-1
Contributors: Tomas Mlcoch; Jan Tuzil; Liliana Sedova; Jiri Stolfa; Monika Urbanova; David Suchy; Andrea Smrzova; Jitka Jircikova; Tereza Hrnciarova; Karel Pavelka et al.
Source: check_circle
Crossref
How many people are using ORCID?